The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Zanubrutinib plus obinutuzumab (ZO) versus obinutuzumab (O) monotherapy in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the phase 2 randomized ROSEWOOD trial.
 
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis
 
Jiří Mayer
Research Funding - BeiGene
 
Rebecca Auer
Consulting or Advisory Role - BeiGene; Incyte
Research Funding - Janssen
 
Fontanet Bijou
Consulting or Advisory Role - Abbvie; AstraZeneca
 
Ana C. de Oliveira
Consulting or Advisory Role - Alexion Pharmaceuticals; Janssen
Travel, Accommodations, Expenses - Janssen
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)
 
Michele Merli
No Relationships to Disclose
 
Krimo Bouabdallah
Honoraria - Abbvie; Kite/Gilead; Roche; Takeda Science Foundation
Consulting or Advisory Role - Kite/Gilead; Roche; Takeda
Travel, Accommodations, Expenses - Roche; Takeda
 
Peter S. Ganly
No Relationships to Disclose
 
Roderick Johnson
Honoraria - Kite/Gilead; Novartis; Takeda
Consulting or Advisory Role - Kite/Gilead
Speakers' Bureau - Kite/Gilead; Novartis
 
Sam Yuen
(OPTIONAL) Uncompensated Relationships - Novartis
 
Ed Kingsley
Employment - Comprehensive Cancer Centers of Nevada
 
Gayane Tumyan
No Relationships to Disclose
 
Sarit E. Assouline
Honoraria - Abbvie; AstraZeneca; BMS; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche/Genentech
Consulting or Advisory Role - Beigene; Roche/Genentech
Research Funding - Astex Pharmaceuticals (Inst); BeiGene (Inst); Novartis (Inst); Roche Canada (Inst); Takeda (Inst)
 
Elena Ivanova
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Honoraria - BeiGene
 
Pil Kim
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene; Protara Therapeutics
Stock and Other Ownership Interests - BeiGene; Roche
Research Funding - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
 
Richard Delarue
Employment - BeiGene; Celgene/Bristol-Myers Squibb
Stock and Other Ownership Interests - BeiGene; Celgene/Bristol-Myers Squibb
 
Judith Trotman
Research Funding - Beigene (Inst); celgene (Inst); Janssen-Cilag (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche/Genentech